Applicability and Safety of Vibration Therapy in Intensive Care Unit (ICU) Patients
NCT ID: NCT01286610
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2011-02-28
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our aim is to show the effects of vibration therapy in ICU patients and its safe applicability.
ADDITION 06th of May 2011: Additionally we will perform euglycaemic hyperinsulinemic clamp and intervention on one day of ICU stay in 20 patients. Under clamp conditions we will perform a vibration therapy (ProMedVi Vibrosphere™) on patients' legs. On top we will perform electrical muscle stimulation (schwa-medico, MUSKELaktiv™) on one ventral upper leg, randomized chosen. Measuring the local skeletal muscle metabolism will be done by microdialysis in Vastus lateralis on both sides - comparing vibration therapy and vibration therapy combined with electrical muscle stimulation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electro-Neuro-Muscular Stimulation in ICU
NCT02011282
MUSCLE EFFECTS OF NEUROMUSCULAR ELECTROSTIMULATION IN MECHANICALLY VENTILATED PATIENTS IN AN ICU
NCT06409611
Effect of Electrical Muscle Stimulation in Critically Ill Patients
NCT01637467
Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients
NCT03083652
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
NCT00709124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vibration therapy and electrical muscle stimulation
ProMedVi Vibrosphere
vibration therapy
schwa-medico MUSKELaktiv
Electrical muscle stimulation
Galileo Home Plus (ICU)
vibration therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ProMedVi Vibrosphere
vibration therapy
schwa-medico MUSKELaktiv
Electrical muscle stimulation
Galileo Home Plus (ICU)
vibration therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with mechanical ventilation without signs of infection
* with mechanical ventilation and SIRS or sepsis
* with mechanical ventilation, with controlled elevated intracranial pressure and with or without SIRS or sepsis
* signed declaration of consent by the patient or its legal proxy
Exclusion Criteria
* already known neuromuscular disease
* missing declaration of consent by the patient or its legal proxy
* implanted heart pacemaker or defibrillator
* pregnancy
* acute thrombosis
* not yet healed fracture ad the part of the body which will be trained
* implants ad the part of the body which will be trained
* a nearly done ophthalmic surgery
* acute disc prolapse
* infaust prognosis, that means death is expected into the next couple of hours, although maximum therapy is done
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steffen Weber-Carstens
Dr. med. Steffen Weber-Carstens, Dept. of Anesthesiology and Intensive Care Medicine, Charite University, Berlin, Germany.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steffen Weber-Carstens, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Anesthesiology and Intensive Care Medicine, Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite University, Berlin, Germany
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wollersheim T, Haas K, Wolf S, Mai K, Spies C, Steinhagen-Thiessen E, Wernecke KD, Spranger J, Weber-Carstens S. Whole-body vibration to prevent intensive care unit-acquired weakness: safety, feasibility, and metabolic response. Crit Care. 2017 Jan 9;21(1):9. doi: 10.1186/s13054-016-1576-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFO192/2-P3-Vibro-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.